Ronald S Lauder Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 17 hours ago
Ronald S Lauder has an estimated net worth of at least $215.0 million*, as of Feb. 12, 2025. They own 0 shares of EL stock. They have sold 700,000 shares of EL stock since 2021, for an estimated $215.0 million.
Ronald S Lauder $EL SEC Form 4 Insider Trading
Ronald S Lauder has filed a total of 1 insider trades in $EL since 2021. Their most recent trade was a sale of 700,000 shares, made on Feb 10, 2022. Their largest trade was a sale of 700,000 shares, made on Feb 10, 2022. We estimate that they now own 0 shares of $EL, worth an estimated $0.
Insider Trading at $EL
There have been a total of 140 insider trades reported at $EL since 2021, with 523,350 shares purchased and 4.0 million shares sold. The most active insider traders in $EL stock have been Fabrizio Freda, Hudis Jane Hertzmark, and John Demsey. The most recent trade was a purchase of 600 shares reported by PAUL J FRIBOURG (None), made on Feb 07, 2025.
History of Insider Stock Trades by Ronald S Lauder
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
![]() |
Sale | 700,000 | Feb 10, 2022 | Feb. 11, 2022, 4:35 p.m. |
$EL Executives and Stock Owners with Insider Trades
-
Fabrizio Freda, President and CEO
-
Hudis Jane Hertzmark, Executive Group President
-
John Demsey, Group President
-
Carl P. Haney, EVP Research Prod & Innovation
-
William P Lauder, Executive Chairman
-
Tracey Thomas Travis, EVP & CFO
-
Jane Lauder, EVP, Enterprise Mkg & CDataO
-
Michael O'Hare, EVP-Global Human Resources
-
Akhil Shrivastava, EVP & CFO
-
Jane Lauder, Executive Vice President & CDO
-
Carl P. Haney, EVP-Global R&D
-
Deirdre Stanley, EVP & General Counsel
-
Peter Jueptner, Group President
-
Ronald S Lauder, Chairman, Clinique Labs, LLC
-
Sara E Moss, Vice Chairman
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.